References
- Stillerman M, Isenberg H, Moody M. Streptococcal pharyngitis therapy. Am J Dis Child 1972; 123: 457–461
- Schwartz R H, Wientzen R L, Pedreira F, Feroli E J, Mella G W, Guandolo V L. Penicillin V for group A Streptococcal pharyngotonsillitis. A randomized trial of seven vs. ten day's therapy. JAMA 1981; 246: 1790–1795
- Kaplan E L, Gastandjy A, Huwe B. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326–335
- Brook I. The role β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984; 6: 601–607
- Crowe C C, Sanders W E, Jr., Longley S. Bacterial interference II. Role of the normal flora in prevention of colonization by group A streptococcus. J Infect Dis 1973; 128: 527–532
- Grahn E, Holm S E. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bacteriol (Orig A) 1983; 256: 72–79
- Kim K S, Kaplan E L. Association of penicillin tolerance with failure to Eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–684
- Speirs C F, Stenhouse D, Stephen K W, Wallace E T. Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin. Br J Pharmacol 1971; 43: 242–246
- Stewart S M, Anderson J, Jones C. Amoxycillin levels in sputum, serum and saliva. Thorax 1974; 29: 110–114
- Eneroth C-M, Lundberg C, Malmström L, Ramström G. Antibiotic concentrations in saliva of purulent parotitis. Scand J Infect Dis 1978; 10: 219–222
- Sprunt K, Leidy G, Redman W. Prevention of bacterial overgrowth. J Infect Dis 1971; 123: 1–10
- Sanders C C, Sanders W E, Jr., Harrowe D J. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun 1976; 13: 808–812
- Holm S E, Falsen E. An antigen-free medium for cultivation of β-hemolytic streptococci. Acta Pathol Microbiol Scand 1967; 69: 264–276
- Grahn E, Holm S E, Ekedahl C, Roos K. Interference of α-hemolytic streptococci isolated from tonsillar surface on β-hemolytic streptococci (Streptococcus pyogenes). A methodological study. Zentralbl Bacteriol (Orig A) 1983; 254: 459–468
- Facklam R R. Physiological differentiation of viridans streptococci. J Clin Microbiol 1977; 5: 184–201
- Roos K, Grahn E, Ekedahl C, Holm S E. Pharmacokinetics of phenoxymethylpenicillin in tonsils. Scand J Infect Dis 1986; 18: 125–130
- Sukchotiratana M, London A H, Fletcher J P. Antibiotics and the oral streptococci of man. J Appl Bacteriol 1975; 38: 277–294
- Eagle H, Musselman A D. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J Exp Med 1948; 88: 99–131
- Tomasz A, Albino A, Zanati E. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 1970; 227: 138–140
- Sabath L D, Wheeler N, Laverdiere M, Blagervic D, Wilkinson B J. A new type of penicillin resistance of Staphylococcus aureus. Lancet 1977; 1: 443–447
- Dajani A S, Law D J, Bollinger O, Ecklund P S. Ultrastructural and biochemical alterations effected by Viridin B, a oacteriocin of alpha-hemolytic streptococci. Infect Immun 1976; 14: 776–782
- Roos K, Brorson J E, Holm S E. Studies in vivo on the killing rate and refractory period of penicillin V in an experimental streptococcal infection. J Antimicrob Chemother 1985; 15: 587–595
- Lorian V, de Freitas C C. Minimal antibiotic concentrations of aminoglycosides and beta-lactam antibiotic of some gram negative bacilli and gram positive cocci. J Infect Dis 1979; 139: 599–603